GNRH1 and ovarian carcinoma: GnRH agonists also decrease the proliferation and promote the apoptosis of ovarian cancer cells, including the SKOV-3 cells used in this study, directly by interacting with GnRH receptors expressed in these cells [3,10,11,22,23,24,25,26,27,28,29,30].